Sarepta Therapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd. SRPT

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

1,082,762

Value ($000)

23,301

Weight

0.1%

2020 Q3 - 2025 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	23,301	0.1%	1,082,762	12/31/2025
2025 Q3	11/13/2025	33,627	0.1%	1,745,051	9/30/2025
2025 Q2	8/7/2025	10,524	0.0%	615,441	6/30/2025
2025 Q1	5/12/2025	15,621	0.1%	244,769	3/31/2025
2024 Q4	2/10/2025	17,902	0.1%	147,236	12/31/2024
2024 Q3	11/8/2024	9,772	0.0%	78,244	9/30/2024
2024 Q2	8/9/2024	9,504	0.0%	60,149	6/30/2024
2024 Q1	5/9/2024	266	0.0%	2,053	3/31/2024
2023 Q3	11/13/2023	9,524	0.0%	78,566	9/30/2023
2023 Q2	8/10/2023	11,239	0.1%	98,143	6/30/2023
2023 Q1	5/10/2023	16,494	0.1%	119,666	3/31/2023
2022 Q4	2/10/2023	15,070	0.1%	116,296	12/31/2022
2022 Q3	11/10/2022	17,436	0.1%	157,731	9/30/2022
2022 Q2	8/5/2022	1,337	0.0%	17,841	6/30/2022
2021 Q1	5/13/2021	386	0.0%	5,184	3/31/2021
2020 Q4	2/16/2021	1,271	0.0%	7,456	12/31/2020
2020 Q3	11/12/2020	1,193	0.0%	8,497	9/30/2020